NCT03387020 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT03387020
Title	Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Pediatric Brain Tumor Consortium
Indications	central nervous system embryonal carcinoma high grade glioma brain stem cancer brain stem glioma medulloblastoma atypical teratoid rhabdoid tumor high grade ependymoma
Therapies	Ribociclib Everolimus + Ribociclib
Age Groups:	child \| adult
Covered Countries	USA

NCT03387020
Clinical Trial Detail